Literature DB >> 15067821

Spectrum of hepatocellular carcinoma at Shifa International Hospital, Islamabad.

Nasir Khokhar1, Ishma Aijazi, Muzaffar Latif Gill.   

Abstract

BACKGROUND: The aim of this study was to review etiological and clinical features of patients with hepatocellular carcinoma (HCC) at a tertiary care centre in past nine years. Relevant data on HCC in other parts of country and world were reviewed.
METHODS: Patients who had biopsy proven HCC were reviewed retrospectively. Demographic features were noted and positivity for serology. presence of cirrhosis. level of alpha-fetoprotein, tumour size and distribution of liver lesions were noted.
RESULTS: A total of 67 patients were found to have biopsy proven HCC. Mean age was 58.64 +/- 12.77 years. Males were 79%. Hepatitis B surface antigen was noted to be positive in 23% of the patients, who were tested and hepatitis C antibody was found to be positive in 67% of the patients who were tested. Alpha fetoprotein level was 632.09 +/- 1332.31. Cirrhosis was noted in 69% patients. Tumour size in patients with single lesion was 6.6 +/- 1.14 cm. Patients with single lesion had 70% time involvement of the left lobe and 30% times had involvement of the right lobe. Fifty one percent of the patients in this series had multilocular distribution.
CONCLUSION: Hepatocellular carcinoma has become a common tumour in Pakistan and studies are showing that this cancer is related to hepatitis C virus infection in majority of the patients. A large number of them have underlying cirrhosis and are multifocal in origin and are presented in an advanced condition.

Entities:  

Mesh:

Year:  2003        PMID: 15067821

Source DB:  PubMed          Journal:  J Ayub Med Coll Abbottabad        ISSN: 1025-9589


  7 in total

Review 1.  Hepatitis C treatment: current and future perspectives.

Authors:  Saira Munir; Sana Saleem; Muhammad Idrees; Aaliyah Tariq; Sadia Butt; Bisma Rauff; Abrar Hussain; Sadaf Badar; Mahrukh Naudhani; Zareen Fatima; Muhmmad Ali; Liaqat Ali; Madiha Akram; Mahwish Aftab; Bushra Khubaib; Zunaira Awan
Journal:  Virol J       Date:  2010-11-01       Impact factor: 4.099

2.  Hepatocellular carcinoma in pakistan: where do we stand?

Authors:  Amna Subhan Butt; Zaigham Abbas; Wasim Jafri
Journal:  Hepat Mon       Date:  2012-10-10       Impact factor: 0.660

3.  Hepatitis C in Pakistan: a review of available data.

Authors:  Muhammad Umar; Hamama Tul Bushra; Masood Ahmad; Available Data; Masood Ahmad; Muhammad Khurram; Saima Usman; Mohammad Arif; Tashfeen Adam; Zahid Minhas; Adnan Arif; Abdul Naeem; Khushnud Ejaz; Zameer Butt; Muhammad Bilal
Journal:  Hepat Mon       Date:  2010-09-01       Impact factor: 0.660

4.  Deal a death blow! HCC in cirrhotics - thrombotic complications: their frequency, characteristics, and risk factors.

Authors:  Khalid Mahmood; Iftikhar Haider Naqvi; Aamer Mahmood; Syed Muhammad; Noor Muhammad
Journal:  Prz Gastroenterol       Date:  2018-03-26

5.  Hepatocellular carcinoma in Native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma.

Authors:  Amna Subhan Butt; Saeed Hamid; Ashfaq Ahmad Wadalawala; Mariam Ghufran; Ammar Asrar Javed; Omer Farooq; Bilal Ahmed; Tanveer Ul Haq; Wasim Jafri
Journal:  BMC Res Notes       Date:  2013-04-08

Review 6.  Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review.

Authors:  Seyed Moayed Alavian; Hossein Haghbin
Journal:  Hepat Mon       Date:  2016-03-06       Impact factor: 0.660

Review 7.  Hepatocellular Carcinoma in Pakistan: National Trends and Global Perspective.

Authors:  Abu Bakar Hafeez Bhatti; Faisal Saud Dar; Anum Waheed; Kashif Shafique; Faisal Sultan; Najmul Hassan Shah
Journal:  Gastroenterol Res Pract       Date:  2016-02-03       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.